GGrantIndex
Sort

17,828 grants matching crispr

Role of Peripheral Inflammation in TBI Pathobiology

$510,015
Pramod K Dash · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · NS

Development of Photoswitchable Nucleotides to Control RNA Biochemistry

$510,000
Jia Sheng · Suny At Albany · · FY2025 · MPS

Kinetic modeling of the CRISPR-Cas9 genome editing system

$510,000
Shi-Jie Chen · University Of Missouri-Columbia · · FY2022 · MPS

Cell Biology of Reovirus Infection

$509,806
Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

Endothelial Transmigration in Neovascular Age-related Macular Degeneration

$509,777
Mary Elizabeth Ruth Hartnett · Stanford University · R01 · FY2023 · EY

Traumatic axonal injury in the visual system: role of dual leucine zipper kinase

$509,574
Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2020 · EY

Traumatic axonal injury in the visual system: role of dual leucine zipper kinase

$509,574
Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2019 · EY

DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications

$509,544
Alan Ashworth · University Of California, San Francisco · R01 · FY2022 · CA

Genetics of Coxiella burnetii

$509,435
Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Traumatic axonal injury in the visual system: role of dual leucine zipper kinase

$509,379
Vassilis E Koliatsos · Johns Hopkins University · R01 · FY2018 · EY

Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer

$509,276
Rosa Ana Risques · University Of Washington · R01 · FY2025 · CA

Genetic variants guiding pathogenicity of colitogenic T cells

$509,240
John Philip Ray · Benaroya Research Inst At Virginia Mason · R01 · FY2025 · DK

Novel DNA damage response therapeutics targeting replication protein A

$509,008
John J Turchi · Indiana University Indianapolis · R01 · FY2021 · CA

Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming

$508,951
Jonathan S. Weissman · University Of California, San Francisco · R01 · FY2013 · DA

Calcium Channels in Glioblastoma

$508,675
Roger Abounader · University Of Virginia · R01 · FY2023 · NS

Novel Glaucoma Treatment Using Genome Editing

$508,558
Val C Sheffield · University Of Iowa · R01 · FY2015 · EY

New and Disruptive Technologies to Study Ubiquitin Biology through Sample Multiplexing

$508,500
Steven P Gygi · Harvard Medical School · R01 · FY2020 · GM

New and Disruptive Technologies to Study Ubiquitin Biology through Sample Multiplexing

$508,500
Steven P Gygi · Harvard Medical School · R01 · FY2019 · GM

New and Disruptive Technologies to Study Ubiquitin Biology through Sample Multiplexing

$508,500
Steven P Gygi · Harvard Medical School · R01 · FY2017 · GM

Histone Variant H3.3 as a Transcription Rheostat in the Immune System

$508,499
Steven Zvi Josefowicz · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI

Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling

$508,476
Benjamin Elison Gewurz · Brigham And Women'S Hospital · R01 · FY2025 · DE

Novel Glaucoma Treatment Using Genome Editing

$508,361
Val C Sheffield · University Of Iowa · R01 · FY2016 · EY

Novel Glaucoma Treatment Using Genome Editing

$508,361
Val C Sheffield · University Of Iowa · R01 · FY2017 · EY

Novel Glaucoma Treatment Using Genome Editing

$508,361
Val C Sheffield · University Of Iowa · R01 · FY2018 · EY

Mechanopriming for cell engineering

$508,355
Song Li · University Of California Los Angeles · R01 · FY2023 · NS